We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+7.42%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$14.1B
AUM Growth
+$2.17B
(+18%)
Cap. Flow
+$1.47B
Cap. Flow
% of AUM
10.47%
Top 10 Holdings %
Top 10 Hldgs %
18.97%
Holding
1,309
New
346
Increased
287
Reduced
265
Closed
392
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$177M |
| 2 |
Lowe's Companies
LOW
|
+$108M |
| 3 |
STJ
St Jude Medical
STJ
|
+$95.4M |
| 4 |
Newell Brands
NWL
|
+$88.6M |
| 5 |
Constellation Brands
STZ
|
+$87.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EMC
EMC CORPORATION
EMC
|
+$136M |
| 2 |
UnitedHealth
UNH
|
+$99.3M |
| 3 |
PayPal
PYPL
|
+$85.4M |
| 4 |
Starbucks
SBUX
|
+$78.1M |
| 5 |
Cigna
CI
|
+$64.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.63% |
| 2 | Consumer Discretionary | 12.48% |
| 3 | Communication Services | 12.09% |
| 4 | Technology | 9.72% |
| 5 | Industrials | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
Globus Medical
GMED
$10.4B
| $482K | ﹤0.01% |
21,347
-37,883
| -64% | -$890K |
|
|
AAC
802
DELISTED
AAC Holdings
AAC
| $482K | ﹤0.01% |
+27,690
| New | +$546K |
|
803
Duluth Holdings
DLTH
$160M
| $477K | ﹤0.01% |
+17,994
| New | +$491K |
|
804
Bank of N.T. Butterfield & Son
NTB
$2.42B
| $474K | ﹤0.01% |
+19,135
| New | +$465K |
|
805
Cedar Fair
FUN
$1.78B
| $470K | ﹤0.01% |
+8,198
| New | +$487K |
|
806
Stellantis
STLA
$16.5B
| $460K | ﹤0.01% |
72,203
+10,847
| +18% | +$71.2K |
|
|
CBI
807
DELISTED
Chicago Bridge & Iron Nv
CBI
| $459K | ﹤0.01% |
16,384
-3,048
| -16% | -$98.8K |
|
808
Monolithic Power Systems
MPWR
$65.5B
| $454K | ﹤0.01% |
+5,637
| New | +$416K |
|
|
GMS
809
DELISTED
GMS Inc
GMS
| $448K | ﹤0.01% |
20,149
-65,051
| -76% | -$1.54M |
|
810
Herbalife
HLF
$1.23B
| $443K | ﹤0.01% |
+14,304
| New | +$452K |
|
811
Plains GP Holdings
PAGP
$5.23B
| $439K | ﹤0.01% |
12,737
-96
| -0.7% | -$2.89K |
|
|
CMD
812
DELISTED
Cantel Medical Corporation
CMD
| $437K | ﹤0.01% |
5,605
-37,735
| -87% | -$2.74M |
|
813
Bio-Techne
TECH
$11.2B
| $434K | ﹤0.01% |
+15,840
| New | +$435K |
|
814
Murphy Oil
MUR
$5.58B
| $432K | ﹤0.01% |
14,209
-102,026
| -88% | -$2.91M |
|
815
Arch Capital
ACGL
$36.1B
| $425K | ﹤0.01% |
16,104
+2,685
| +20% | +$68.3K |
|
|
PETX
816
DELISTED
Aratana Therapeutics, Inc.
PETX
| $424K | ﹤0.01% |
+45,255
| New | +$376K |
|
|
KANG
817
DELISTED
iKang Healthcare Group, Inc.
KANG
| $416K | ﹤0.01% |
23,018
| – | – |
|
818
Brookfield
BN
$102B
| $411K | ﹤0.01% |
32,719
-698,833
| -96% | -$8.56M |
|
819
Columbia Sportswear
COLM
$3.19B
| $408K | ﹤0.01% |
7,187
-1,818
| -20% | -$104K |
|
|
ELP
820
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
| $408K | ﹤0.01% |
98,258
+26,650
| +37% | +$108K |
|
821
Argan
AGX
$7.98B
| $407K | ﹤0.01% |
+6,875
| New | +$337K |
|
|
CXP
822
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
| $407K | ﹤0.01% |
+18,200
| New | +$424K |
|
|
S
823
DELISTED
Sprint Corporation
S
| $407K | ﹤0.01% |
+61,408
| New | +$364K |
|
824
Tyson Foods
TSN
$20.2B
| $401K | ﹤0.01% |
5,374
-1,518
| -22% | -$111K |
|
|
GNMK
825
DELISTED
GenMark Diagnostics, Inc
GNMK
| $400K | ﹤0.01% |
+33,938
| New | +$328K |
|
Similar funds
Marshall Wace's Q3 2016 Portfolio in Review
As of Q3 2016, Marshall Wace held 1,309 positions worth $14.1B, up 18% from $11.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Marshall Wace deployed $1.47B of net new capital in Q3 2016, opening 346 new positions and adding to 287 existing holdings. Its largest new stake was St Jude Medical: 1,181,595 shares worth $94.2M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was UnitedHealth, an estimated $99.3M trimmed.
- Marshall Wace's largest Q3 2016 buy was St Jude Medical: 1,181,595 shares worth $94.2M.
- Marshall Wace added most to Zoetis in Q3 2016, an estimated $177M increase.
- Marshall Wace's biggest Q3 2016 reduction was UnitedHealth, cutting an estimated $99.3M.
- Marshall Wace fully exited EMC CORPORATION in Q3 2016, selling an estimated $136M.
- Marshall Wace's ten largest holdings make up 19% of its $14.1B portfolio in Q3 2016.
- Marshall Wace opened 346 new positions and closed 392 in Q3 2016.
- Marshall Wace's portfolio value rose 18% quarter-over-quarter to $14.1B.
Based on Marshall Wace's 13F filing for Q3 2016, filed 10 Nov 2016.